bpi-361175
Small moleculeexperimental
Clinical trial activity
2 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jul 21, 2021 (NCT05329298)
Timeline
2020s
- Jan 1, 2021
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05393466 | Phase 1/Phase 2 (Phase 2) | Jul 1, 2023 | Xcovery |
| NCT05329298 | Phase 1/Phase 2 (Phase 2) | Jul 21, 2021 | Betta Pharmaceuticals Co.,Ltd., Huazhong University of Science and Technology, Zhejiang University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Betta Pharmaceuticals Co.,Ltd. | For profit | 1 | 1 | 1 | 2021 |
| Huazhong University of Science and Technology | Academic/Hospital | 1 | 0 | 1 | 2021 |
| Xcovery | For profit | 1 | 1 | 1 | 2023 |
| Zhejiang University | Academic/Hospital | 1 | 0 | 1 | 2021 |
4 organizations
Page 1 / 1